z-logo
open-access-imgOpen Access
Kernel machine score test for pathway analysis in the presence of semi-competing risks
Author(s) -
Matey Neykov,
Boris P. Hejblum,
Jennifer A. Sinnott
Publication year - 2016
Publication title -
statistical methods in medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.952
H-Index - 85
eISSN - 1477-0334
pISSN - 0962-2802
DOI - 10.1177/0962280216653427
Subject(s) - resampling , survival analysis , proportional hazards model , statistical hypothesis testing , hazard ratio , null distribution , medicine , computer science , statistics , test statistic , mathematics , artificial intelligence , confidence interval
In cancer studies, patients often experience two different types of events: a non-terminal event such as recurrence or metastasis, and a terminal event such as cancer-specific death. Identifying pathways and networks of genes associated with one or both of these events is an important step in understanding disease development and targeting new biological processes for potential intervention. These correlated outcomes are commonly dealt with by modeling progression-free survival, where the event time is the minimum between the times of recurrence and death. However, identifying pathways only associated with progression-free survival may miss out on pathways that affect time to recurrence but not death, or vice versa. We propose a combined testing procedure for a pathway's association with both the cause-specific hazard of recurrence and the marginal hazard of death. The dependency between the two outcomes is accounted for through perturbation resampling to approximate the test's null distribution, without any further assumption on the nature of the dependency. Even complex non-linear relationships between pathways and disease progression or death can be uncovered thanks to a flexible kernel machine framework. The superior statistical power of our approach is demonstrated in numerical studies and in a gene expression study of breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here